Richard A. Fair
2020
In 2020, Richard A. Fair earned a total compensation of $2.7M as President and Chief Executive Officer at BELLICUM PHARMACEUTICALS, a 55% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $249,190 |
|---|---|
| Option Awards | $1,786,412 |
| Salary | $625,910 |
| Other | $21,433 |
| Total | $2,682,945 |
Fair received $1.8M in option awards, accounting for 67% of the total pay in 2020.
Fair also received $249.2K in non-equity incentive plan, $625.9K in salary and $21.4K in other compensation.
Rankings
In 2020, Richard A. Fair's compensation ranked 4,279th out of 13,090 executives tracked by ExecPay. In other words, Fair earned more than 67.3% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 4,279 out of 13,090 | 67th |
Division Manufacturing | 1,731 out of 5,624 | 69th |
Major group Chemicals And Allied Products | 673 out of 2,257 | 70th |
Industry group Drugs | 575 out of 1,957 | 71st |
Industry Pharmaceutical Preparations | 438 out of 1,462 | 70th |
Source: SEC filing on April 29, 2021.
Fair's colleagues
We found two more compensation records of executives who worked with Richard A. Fair at BELLICUM PHARMACEUTICALS in 2020.